OAM
FOLD

Oppenheimer Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Oppenheimer Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,260
Closed -$219K – 1150
2024
Q4 		$219K Sell
23,260
-9,740
-30% -$101K ﹤0.01% 1060
2024
Q3 		$352K Sell
33,000
-18,352
-36% -$200K ﹤0.01% 955
2024
Q2 		$509K Buy
51,352
+11
+0% +$113 0.01% 856
2024
Q1 		$605K Buy
51,341
+158
+0.3% +$2.02K 0.01% 791
2023
Q4 		$726K Sell
51,183
-7,863
-13% -$89.3K 0.01% 779
2023
Q3 		$718K Sell
59,046
-200
-0.3% -$2.58K 0.01% 767
2023
Q2 		$744K Sell
59,246
-3,368
-5% -$40K 0.01% 764
2023
Q1 		$694K Sell
62,614
-4,464
-7% -$55K 0.01% 767
2022
Q4 		$819K Buy
67,078
+12,206
+22% +$137K 0.01% 724
2022
Q3 		$573K Sell
54,872
-2,151
-4% -$24K 0.01% 798
2022
Q2 		$612K Sell
57,023
-3,111
-5% -$25.6K 0.01% 803
2022
Q1 		$569K Buy
60,134
+5,265
+10% +$49.4K 0.01% 888
2021
Q4 		$634K Buy
54,869
+11,817
+27% +$132K 0.01% 903
2021
Q3 		$411K Sell
43,052
-2,653
-6% -$27.1K 0.01% 978
2021
Q2 		$441K Sell
45,705
-797
-2% -$7.78K 0.01% 989
2021
Q1 		$459K Buy
+46,502
New +$720K 0.01% 933

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Oppenheimer Asset Management's FOLD Position: Q1 2025 in Review

Oppenheimer Asset Management sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 23,260 shares — an estimated $219K sold.

Oppenheimer Asset Management first reported a position in FOLD in Q1 2021 and held it in 16 quarters. The position peaked at $819K in Q4 2022. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.

  • Oppenheimer Asset Management reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 23,260 Amicus Therapeutics shares in Q1 2025, an estimated $219K.
  • Oppenheimer Asset Management first reported a position in Amicus Therapeutics in Q1 2021 and held it in 16 quarters.
  • Oppenheimer Asset Management's Amicus Therapeutics position peaked at $819K in Q4 2022.
  • 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.

Based on Oppenheimer Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.